Form 4: Elanco Animal Health Executive Sells Shares in Transaction

Grace McArdle, EVP of Manufacturing and Quality at Elanco Animal Health, disposed of 351 shares of common stock on January 3, 2025.

Summary

• Grace McArdle, an Executive Vice President at Elanco Animal Health, sold 351 shares of the company's common stock.
• The transaction occurred on January 3, 2025.
• The sale price was $11.98 per share.
• Following the transaction, Ms. McArdle directly owns 50,212 shares of Elanco stock.

Sentiment

Score: 5

Explanation: The document is a neutral report of an executive stock sale, which is a common occurrence and does not inherently indicate positive or negative sentiment.

Industry Context

This is a routine filing related to insider trading activity and is common for executives of publicly traded companies. It does not indicate any specific trend in the animal health industry.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, such as Zoetis and IDEXX Laboratories, where executives are required to disclose their transactions in company stock.
• The transaction is relatively small compared to the overall trading volume of Elanco stock and is not unusual for executive stock transactions.

Stakeholder Impact

• The transaction is unlikely to have a significant impact on shareholders, employees, customers, suppliers, or creditors due to the small size of the transaction.

Key Dates

Keywords

Elanco Animal Health, stock sale, insider trading, executive transaction, Form 4, share disposal, Grace McArdle